Bank Julius Baer & Co’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.98M Buy
53,783
+5,555
+12% +$1.03M 0.03% 187
2025
Q1
$10.8M Buy
48,228
+647
+1% +$145K 0.04% 185
2024
Q4
$8.95M Buy
47,581
+4,790
+11% +$901K 0.03% 211
2024
Q3
$9.35M Buy
42,791
+6,399
+18% +$1.4M 0.03% 193
2024
Q2
$6.83M Sell
36,392
-10,990
-23% -$2.06M 0.03% 173
2024
Q1
$8.55M Buy
47,382
+5,639
+14% +$1.02M 0.03% 174
2023
Q4
$6.47M Buy
41,743
+12,361
+42% +$1.92M 0.03% 193
2023
Q3
$4.38M Buy
29,382
+1,299
+5% +$194K 0.03% 183
2023
Q2
$3.78M Sell
28,083
-4,833
-15% -$651K 0.02% 189
2023
Q1
$5.25M Buy
32,916
+1,011
+3% +$161K 0.03% 181
2022
Q4
$5.16M Sell
31,905
-39
-0.1% -$6.3K 0.04% 181
2022
Q3
$4.29M Buy
31,944
+1,766
+6% +$237K 0.03% 170
2022
Q2
$4.62M Buy
30,178
+1,734
+6% +$266K 0.03% 173
2022
Q1
$4.61M Sell
28,444
-6,982
-20% -$1.13M 0.03% 176
2021
Q4
$4.8M Buy
35,426
+2,070
+6% +$280K 0.03% 205
2021
Q3
$3.6M Buy
33,356
+17,323
+108% +$1.87M 0.02% 212
2021
Q2
$1.81M Buy
16,033
+1,897
+13% +$214K 0.01% 294
2021
Q1
$1.53M Buy
14,136
+16
+0.1% +$1.73K 0.01% 291
2020
Q4
$1.51M Buy
14,120
+5,174
+58% +$554K 0.01% 290
2020
Q3
$784K Buy
8,946
+413
+5% +$36.2K 0.01% 322
2020
Q2
$836K Buy
8,533
+1,377
+19% +$135K 0.01% 296
2020
Q1
$545K Buy
+7,156
New +$545K 0.01% 303